Real Price to Acquire Entire Company: zimvie.com (ZIMV)

Brandmark of ZimVie Corp (ZIMV)

ZimVie Inc. (ZIMV) current profit growth is based on the concentration of resources in the lucrative high-cost dental implant sector. The company maintains a technological edge by implementing advanced biomaterials for spinal and dental surgeries. The market valuation dynamics for the asset on GURU.Markets stand at , while the business optimizes costs by outsourcing the production of basic components and global delivery to third-party contractors.

ZIMV (ZimVie Dental) Total Company Value history from 07/04/2022 to 10/29/2026
Manufactured product of ZimVie Inc

Steady demand for ZimVie Inc. (ZIMV) dental equipment within a neutral geopolitical environment creates a predictable cash flow. Enterprise Value (EV) sums the market capitalization and net debt, reflecting the total acquisition price of the business. Investors use this metric to compare actual purchase costs with operational efficiency. Analyzing the company's aggregate valuation level helps avoid overpaying for assets. An upward trend on this chart signals a potential overvaluation of the business.

Who ZimVie Inc. competes with

Company Buyout Price Intuitive Surgical, Inc. (ISRG)|DHR - Total Company Value|Becton Dickinson & Company (BDX) - Real Price to Acquire Entire Company|STE (STERIS plc) - Real Price to Acquire Entire Company|WST (westpharma.com) - Total Company Value|Total Company Value Baxter|Real Price to Acquire Entire Company Masimo Corp (MASI)|Enterprise Value STVN|TFX - Total Enterprise Value|Enterprise Value MMSI (Merit Medical Systems)|NVST: Business Value|ICU Medical - Enterprise Value|Company Buyout Price Dentsply Sirona Inc XRAY|LMAT: Enterprise Value|Real Price to Acquire Entire Company AtriCure Medical|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value Niagen|Total Company Value AngioDynamics (ANGO)|Total Company Value CERS (Cerus Corp.)|Alpha Teknova Inc - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash MGRM|Sharps Tech - Enterprise Value|Company Buyout Price InfuSystem Holdings INFU|Utah Medical Products, Inc. (UTMD) - Total Company Value|Business Value KRMD|Total Company Value Nyxoah, S.A.|Microbot Medical, Inc (MBOT) - Company Buyout Price|Real Price to Acquire Entire Company PDEX (Pro-Dex, Inc.)|Aggregate Business Value ZTEK|Total Company Value Elutia ELUT|Value Adjusted for Debt and Cash MLSS|NXGL: Real Price to Acquire Entire Company|RVP - Enterprise Value|Harvard Bioscience (HBIO) - Total Company Value|Real Price to Acquire Entire Company femasys.com|MHUA (Meihua Medical Technologies) - Enterprise Value|Total Enterprise Value Predictive Oncology Corp POAI|Total Company Value Callan JMB Inc (CJMB)|Atrion Corporation Inc. - Business Value|NeuroMetrix, Inc. - Real Price to Acquire Entire Company